GoAI
Get started
Revolution Medicines, Inc. logo

Revolution Medicines, Inc.

RVMD

NASDAQHealthcareBiotechnology

Open in GoAI

Previous close

$209.46

−$2.275 · -1.07%

Aug 21, 4:00 PM ET

RVMD company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

31

Expensive

Momentum

65

Gaining

Sentiment

56

Mixed

Risk resilience

65

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $209.46

52-week range

Current $209.46

Open
$212.06
Previous close
$211.74
Volume
2.12M
Market cap
44.53B USD
50-day average
$187
+12.01% above average
200-day average
$126.66
+65.37% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
14.92B USD
P/E (TTM)
-23.64×
P/B (TTM)
16.95×
P/S (TTM)
0×
EV / EBITDA
-13.68×
Earnings yield
-7.47%
Free cash flow yield
-6.03%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
0.00%
Operating margin
0.00%
Net margin
0.00%
Return on equity
-69.35%
Return on assets
-48.05%
Return on invested capital
-56.83%

Financial health

Debt / equity
0.25×
Current ratio
7.14×
Altman Z-score
13.99
Piotroski F-score
1 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends531%-1192%-2915%-4638%Gross margin, FY2021: 100.00%Gross margin, FY2022: 100.00%Gross margin, FY2023: 100.00%Operating margin, FY2021: -639.70%Operating margin, FY2022: -730.01%Operating margin, FY2023: -4207.12%Net margin, FY2021: -636.58%Net margin, FY2022: -702.95%Net margin, FY2023: -3768.28%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 100.00%. Gross margin FY2022 100.00%. Gross margin FY2023 100.00%. Operating margin FY2021 -639.70%. Operating margin FY2022 -730.01%. Operating margin FY2023 -4207.12%. Net margin FY2021 -636.58%. Net margin FY2022 -702.95%. Net margin FY2023 -3768.28%.

Income trends

Revenue

11.58M USD-67.27%

Operating income

−1.18B USD-71.48%

Net income

−1.13B USD-88.52%
Income trends across reported periods157.15M USD−329.94M USD−817.04M USD−1.3B USDRevenue, FY2021: 29.39M USDRevenue, FY2022: 35.38M USDRevenue, FY2023: 11.58M USDOperating income, FY2021: −188.01M USDOperating income, FY2022: −258.28M USDOperating income, FY2023: −487.19M USDOperating income, FY2024: −689.52M USDOperating income, FY2025: −1.18B USDNet income, FY2021: −187.09M USDNet income, FY2022: −248.71M USDNet income, FY2023: −436.37M USDNet income, FY2024: −600.09M USDNet income, FY2025: −1.13B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 29.39M USD. Revenue FY2022 35.38M USD. Revenue FY2023 11.58M USD. Operating income FY2021 −188.01M USD. Operating income FY2022 −258.28M USD. Operating income FY2023 −487.19M USD. Operating income FY2024 −689.52M USD. Operating income FY2025 −1.18B USD. Net income FY2021 −187.09M USD. Net income FY2022 −248.71M USD. Net income FY2023 −436.37M USD. Net income FY2024 −600.09M USD. Net income FY2025 −1.13B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue——11.58M USD35.38M USD29.39M USD
Cost of goods sold16.56M USD————
Gross profit−16.56M USD—11.58M USD35.38M USD29.39M USD
Research and development978.68M USD592.23M USD423.14M USD253.07M USD186.95M USD
Selling, general, and administrative187.13M USD97.3M USD75.62M USD40.59M USD30.45M USD
Operating expenses1.17B USD689.52M USD498.77M USD293.66M USD217.4M USD
Interest income90.69M USD86.88M USD47.48M USD9.15M USD929K USD
Interest expense24.23M USD—303K USD—12K USD
Depreciation and amortization16.56M USD11.82M USD9.31M USD9.66M USD7.33M USD
Operating income−1.18B USD−689.52M USD−487.19M USD−258.28M USD−188.01M USD
Net income−1.13B USD−600.09M USD−436.37M USD−248.71M USD−187.09M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$207.54

0.92% downside
Past 12 months12-month forecastHigh $240Average $207.54Low $144

Rating distribution

24 ratings
Strong buy14%
Buy2188%
Hold28%
Sell00%
Strong sell00%

RVMD peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding RVMD

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
1.21B
Weight
0.05%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
870.53M
Weight
0.47%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETF logoVanguard Morningstar Small-Cap Growth ETFVBK
Market value
503.57M
Weight
1.13%
AUM
43.8B USD
Expense ratio
0.05%
Price / 1D
$358.65+0.70%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
431.63M
Weight
0.45%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Biotechnology ETF logoiShares Biotechnology ETFIBB
Market value
301.4M
Weight
2.84%
AUM
10.75B USD
Expense ratio
0.44%
Price / 1D
$213.56+1.29%
iShares Russell Mid-Cap Growth ETF logoiShares Russell Mid-Cap Growth ETFIWP
Market value
233.47M
Weight
1.14%
AUM
20.62B USD
Expense ratio
0.23%
Price / 1D
$143.66+0.99%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
202.26M
Weight
0.88%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%
iShares Russell Mid-Cap ETF logoiShares Russell Mid-Cap ETFIWR
Market value
164.89M
Weight
0.29%
AUM
57.66B USD
Expense ratio
0.18%
Price / 1D
$113.44+0.70%

Continue in GoAI

Research RVMD

research.disclaimer